This is a StreetInsider.com Premium Only Page

(INVO) –

Apr 17, 2024 05:03 PM Form 10-K/A INVO Bioscience, Inc. For: Dec 31

Apr 17, 2024 03:16 PM Form 8-K INVO Bioscience, Inc. For: Apr 17

Apr 16, 2024 04:59 PM INVO Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 16, 2024 04:56 PM Form 8-K INVO Bioscience, Inc. For: Apr 16

Apr 16, 2024 04:51 PM Form 10-K INVO Bioscience, Inc. For: Dec 31

Apr 11, 2024 05:29 PM Form 8-K INVO Bioscience, Inc. For: Apr 05

Apr 5, 2024 02:36 AM Asian stocks sink as rate jitters worsen ahead of US payrolls data

Apr 2, 2024 05:20 PM Form 8-K/A INVO Bioscience, Inc. For: Mar 27

Apr 1, 2024 04:19 PM Form NT 10-K INVO Bioscience, Inc. For: Dec 31

Apr 1, 2024 04:03 PM Form 8-K INVO Bioscience, Inc. For: Mar 27

Mar 29, 2024 04:41 PM Form 424B5 INVO Bioscience, Inc.

Mar 27, 2024 05:24 PM Form 10-K/A INVO Bioscience, Inc. For: Dec 31

Mar 1, 2024 05:17 PM Form 8-K INVO Bioscience, Inc. For: Feb 26

Feb 6, 2024 10:25 AM Form SC 13G/A INVO Bioscience, Inc. Filed by: INTRACOASTAL CAPITAL, LLC

Feb 1, 2024 09:01 AM Form 8-K INVO Bioscience, Inc. For: Jan 19

Jan 23, 2024 08:08 AM NAYA Biosciences (INVO) to Acquire Florida Biotechnologies

Jan 23, 2024 08:00 AM NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)

Jan 16, 2024 05:31 PM Form S-4 INVO Bioscience, Inc.

Jan 10, 2024 04:46 PM Form 8-K/A INVO Bioscience, Inc. For: Dec 27

Jan 10, 2024 04:06 PM Form 8-K INVO Bioscience, Inc. For: Jan 04

Jan 3, 2024 05:30 PM Form 8-K INVO Bioscience, Inc. For: Dec 27

Dec 28, 2023 05:05 PM Form 424B7 INVO Bioscience, Inc.

Dec 28, 2023 05:03 PM Form 8-K INVO Bioscience, Inc. For: Dec 28

Dec 28, 2023 06:00 AM Form 8-K INVO Bioscience, Inc. For: Dec 26

Dec 13, 2023 05:09 PM Form DEFA14A INVO Bioscience, Inc.

Dec 13, 2023 04:53 PM Form 8-K INVO Bioscience, Inc. For: Dec 12

Dec 11, 2023 08:00 AM NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal

Dec 6, 2023 09:00 AM NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therap

Nov 28, 2023 05:19 PM Form 8-K INVO Bioscience, Inc. For: Nov 22

Nov 28, 2023 09:00 AM INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

Nov 24, 2023 01:09 PM Form DEF 14A INVO Bioscience, Inc. For: Nov 24

Nov 20, 2023 05:00 PM Form 8-K INVO Bioscience, Inc. For: Nov 19

Nov 13, 2023 04:12 PM Form 8-K INVO Bioscience, Inc. For: Nov 13

Nov 13, 2023 04:09 PM Form 10-Q INVO Bioscience, Inc. For: Sep 30

Nov 13, 2023 04:03 PM INVO Bioscience (INVO) Tops Q3 EPS by $1.50

Nov 13, 2023 04:01 PM INVO Reports Record Third Quarter 2023 Financial Results

Nov 13, 2023 09:26 AM Form SC TO-C INVO Bioscience, Inc. Filed by: INVO Bioscience, Inc.

Nov 13, 2023 09:22 AM Form 8-K INVO Bioscience, Inc. For: Nov 13

Nov 13, 2023 09:15 AM Form PRE 14A INVO Bioscience, Inc. For: Nov 13

Nov 13, 2023 06:02 AM Form 8-K INVO Bioscience, Inc. For: Nov 09

Nov 10, 2023 09:01 AM INVO Bioscience (INVO) and NAYA Appoints Peter Kash as Vice Chairman Following Closing of Their Pending Merger

Nov 10, 2023 09:00 AM NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger

Nov 9, 2023 04:40 PM INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants

Oct 27, 2023 09:00 AM Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday,

Oct 26, 2023 04:57 PM Form 8-K INVO Bioscience, Inc. For: Oct 22

Oct 25, 2023 07:49 AM MainFirst Bank AG Downgrades INVO Bioscience Inc. (INVO) to Hold

Oct 24, 2023 05:11 PM Form 8-K INVO Bioscience, Inc. For: Oct 23

Oct 24, 2023 10:08 AM Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm

Oct 23, 2023 07:32 AM INVO Bioscience (INVO) and NAYA Biosciences Announce Definitive Merger Agreement

Oct 23, 2023 07:30 AM INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company